Child Advocate for Diabetes Research in Canada Joins Children Across the
Help Find a Cure for Diabetes
TORONTO, June 20, 2011 /CNW/ - Myriam Paquin, 13, is one of seven
children from around the world selected to attend JDRF's Children's
Congress 2011 in Washington, D.C., United States, on June 20 to 22,
2011. Myriam, representing JDRF's Canadian affiliate, will join 150
delegates from across the United States to convey a clear message to
the U.S. government that type 1 diabetes is a global problem requiring
a united effort to find better treatments and a cure for the disease.
Fluently bilingual in French and English, Myriam has long been a
positive advocate for improving the lives of those living with type 1
diabetes in Canada. She has delivered speeches at fundraising events,
given media interviews and carried the cause to Parliament Hill in
Ottawa. She has inspired family and friends to campaign for more
research funds to find a cure for type 1 diabetes and for improved
access to insulin pump therapy right across Canada.
Myriam not only comes to Washington, D.C. as a representative for
children with diabetes in Canada but for all children around the world
affected by this disease. Joining Myriam in Washington, D.C. will be
other JDRF Children's Congress International delegates from Australia,
Denmark, Israel, the Netherlands, Mexico and the United Kingdom.
Type 1 diabetes, the most severe form of diabetes, is a non-preventable
autoimmune disease that can occur at any age but is most commonly
diagnosed from infancy to the late 30s.1 More than 300,000 Canadians and their families suffer from this disease
and are faced with its devastating complications.2
Myriam was diagnosed with diabetes when she was two years old. For
Myriam and her family, managing diabetes is a daily struggle to
maintain balance through frequent blood sugar checks and regular
administration of insulin.
"Living with diabetes makes life a constant worry 24/7 - it's like being
in a storm in an airplane - despite all the precautions, you never know
if you are going to crash, make it through fine, or end up flying
higher," says Myriam. "I am honoured to represent JDRF Canada at such
a distinguished event so that I can represent all the voices of
Canadians with type 1 diabetes that want a cure and a better life."
While in Washington, D.C., Myriam will be paired with a "buddy" from
among the U.S. delegates. These children will be given a unique
opportunity to learn first-hand from each other about advocacy efforts
in their country. Their networking and learning experience at
Children's Congress will be beneficial in implementing future advocacy
programs in Canada.
Led by International Chairman Mary Tyler Moore, JDRF's Children's
Congress 2011 will include Congressional visits by the child delegates
and a Congressional hearing where Ms. Moore, select child delegates,
researchers, and business and community leaders will testify on the
need for continued support of funding in the U.S. for diabetes
research, under the theme of "Promise to Remember Me." This theme
serves as a powerful call to lawmakers to remember their struggle and
the importance of supporting funding of type 1 diabetes research.
JDRF's Children's Congress, held every other year since 1999, has become
the largest media and grassroots advocacy event held in support of
finding better treatments and a cure for type 1 diabetes. The
newly-selected delegates will follow in the footsteps of their
predecessors in raising national awareness for type 1 diabetes and
participating in personal advocacy at the highest level of the United
About JDRF Canada
JDRF is the leading charitable funder and advocate of type 1 diabetes
research worldwide. JDRF's mission is to find a cure for diabetes and
its complications through the support of research. JDRF funding and
leadership is associated with most major scientific breakthroughs in
type 1 diabetes research to date in Canada and around the world. It has
raised more than $1.5 billion for diabetes research since its inception
in 1970, including $107 million in 2010. JDRF raises funds in 7
countries, and is funding research in 19, including over 50 human
clinical trials. Over 80% of the funds JDRF expends support research
and research related education. For more information, please visit www.jdrf.ca.
JDRF is the worldwide leader for research to cure type 1 diabetes. It
sets the global agenda for diabetes research, and is the largest
charitable funder and advocate of diabetes science worldwide.
The mission of JDRF is to find a cure for diabetes and its complications
through the support of research. Type 1 diabetes is an autoimmune
disease that strikes children and adults suddenly, and can be fatal.
Until a cure is found, people with type 1 diabetes have to test their
blood sugar and give themselves multiple daily insulin injections or
use a pump - each day, every day of their lives. And even with that
intensive care, insulin is not a cure for diabetes, nor does it prevent
its potential complications, which may include kidney failure,
blindness, heart disease, stroke, and amputation.
Since its founding in 1970 by parents of children with type 1 diabetes,
JDRF has awarded more than $1.5 billion to diabetes research, including
$107 million last year. More than 80 percent of JDRF's expenditures
directly support research and research-related education. For more
information, please visit www.jdrf.org.
1 JDRF. What is Diabetes?. Accessed March 2011.
2 JDRF. Type 1 Fact Sheet. Accessed March 2011.
SOURCE Juvenile Diabetes Research Foundation
For further information:
647 789 2025